Nuvalent, Inc. (NASDAQ:NUVL – Get Score) insider Deborah Ann Miller bought 2,000 shares of the corporate’s inventory in a transaction that occurred on Thursday, December fifteenth. The shares had been bought at a mean value of $29.98, for a complete transaction of $59,960.00. The sale was disclosed in a authorized submitting with the SEC, which could be accessed by way of this hyperlink.
Deborah Ann Miller additionally lately made the next commerce(s):
- On Tuesday, November fifteenth, Deborah Ann Miller bought 2,000 shares of Nuvalent inventory. The shares had been bought at a mean value of $31.91, for a complete transaction of $63,820.00.
Nuvalent Inventory Efficiency
Shares of NUVL traded down $0.16 throughout mid-day buying and selling on Friday, reaching $29.57. The inventory had a buying and selling quantity of 1,586,899 shares, in comparison with its common quantity of 224,481. The agency has a market cap of $1.67 billion, a price-to-earnings ratio of -19.69 and a beta of 1.60. Nuvalent, Inc. has a 12 month low of $7.09 and a 12 month excessive of $40.43. The enterprise has a fifty day shifting common of $28.22 and a 200 day shifting common of $19.75.
Hedge Funds Weigh In On Nuvalent
A lot of hedge funds have lately modified their holdings of NUVL. New York State Frequent Retirement Fund boosted its place in shares of Nuvalent by 65.6% within the first quarter. New York State Frequent Retirement Fund now owns 12,922 shares of the corporate’s inventory value $179,000 after buying a further 5,120 shares throughout the interval. JPMorgan Chase & Co. boosted its place in shares of Nuvalent by 13.0% within the first quarter. JPMorgan Chase & Co. now owns 442,575 shares of the corporate’s inventory value $6,147,000 after buying a further 50,930 shares throughout the interval. Financial institution of New York Mellon Corp boosted its place in shares of Nuvalent by 57.8% within the first quarter. Financial institution of New York Mellon Corp now owns 45,656 shares of the corporate’s inventory value $634,000 after buying a further 16,726 shares throughout the interval. MetLife Funding Administration LLC boosted its place in shares of Nuvalent by 196.6% within the first quarter. MetLife Funding Administration LLC now owns 12,959 shares of the corporate’s inventory value $180,000 after buying a further 8,590 shares throughout the interval. Lastly, Rhumbline Advisers purchased a brand new place in shares of Nuvalent throughout the first quarter value $211,000. 95.07% of the inventory is at present owned by institutional traders.
Analyst Upgrades and Downgrades
Individually, BMO Capital Markets upped their goal value on shares of Nuvalent from $28.00 to $50.00 and gave the corporate a “purchase” ranking in a report on Friday, October twenty eighth.
About Nuvalent
(Get Score)
Nuvalent, Inc, a scientific stage biopharmaceutical firm, develops therapies for sufferers with most cancers. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that specific the conventional ROS1 kinase area with none drug-resistant mutations and stay lively within the presence of mutations conferring resistance to accepted and investigational ROS1 inhibitors, which is underneath Section I improvement; and NVL-655, a brain-penetrant ALK-selective inhibitor, to handle the scientific challenges of emergent remedy resistance, central nervous system-related hostile occasions, and mind metastases which may restrict using first-, second-, and third-generation ALK inhibitors that’s underneath Section I/II scientific trial.
Additional Studying
This prompt information alert was generated by narrative science know-how and monetary knowledge from MarketBeat with a view to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial staff previous to publication. Please ship any questions or feedback about this story to contact@marketbeat.com.
Earlier than you think about Nuvalent, you will need to hear this.
MarketBeat retains observe of Wall Avenue’s top-rated and finest performing analysis analysts and the shares they suggest to their shoppers each day. MarketBeat has recognized the 5 shares that prime analysts are quietly whispering to their shoppers to purchase now earlier than the broader market catches on… and Nuvalent wasn’t on the checklist.
Whereas Nuvalent at present has a “Purchase” ranking amongst analysts, top-rated analysts imagine these 5 shares are higher buys.
View The 5 Shares Right here
